Xuesong Chen Wangjian Zha Mei Su Nan Meng Shuliang Cao Beifang Niu Xu Qi
10.3389/fphar.2023.1053805
Front Pharmacol
2023 Feb 3;14:1053805.
egfr exon 20 insertions anlotinib case report furmonertinib lung adenocarcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/36817153/
Case Reports
PMC9935568
36817153
Persistent response of furmonertinib plus anlotinib in a lung adenocarcinoma patient with an EGFR exon 20 insertion mutation: A case report
2023